Key result
Antiplatelet agents improve prognosis in high-risk patients with CAD.
Why the study?
There has been a substantial expansion in antiplatelet agents and understanding of their clinical importance in high-risk coronary artery disease patients.
A comprehensive review highlighting the essential role of various antiplatelet agents in improving the prognosis of high-risk patients with coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Supports antiplatelet use in high-risk CAD; leaves open optimal regimens for contemporary trials.
Shung Chull Chae (2004) conducted a review in Coronary Artery Disease. Antiplatelet agents was evaluated. Antiplatelet agents, including aspirin, thienopyridines, and glycoprotein IIb/IIIa blockers, improve the prognosis of high-risk patients with coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: